At a glance
ClinicalIndex Comparison RecordN/ACompleted· 112 enrolled
Drug / intervention
Ivabradine 7.5mg orallydrug
Likely dose
Ivabradine 7.5mg orallyfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Heart Rate Reducing Therapy With Ivabradine and Bisoprolol Before Coronary Computer Tomographic Angiography in Ambulant Patients
In Brief
An observational study evaluating Ivabradine 7.5mg orally for Bradycardia. Completed, enrolled 112 participants.
Detailed Summary
Out-patients scheduled for coronary computer tomographic angiography (CCTA) were screened regarding their baseline heart rate. If heart rate was \> 75, patients were pretreated with 10mg bisoprolol (group 1) or 10mg bisoprolol plus 7.5mg ivabradine (group 2) to reduce heart rate one our before CCTA was performed. Heart rate, additional use of i.v. bradycardic agents, motion artefacts, radiation dose and drug tolerance was monitored.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
Primary CompletionSep 2015
Study CompletionJan 2016
First PostedMay 2016
TodayJul 2026
First PostedMay 6, 2016
Enrollment StartFeb 1, 2015
Primary CompletionSep 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.2 years ago
Interventions
Ivabradine 7.5mg orallydrug
additive use to the standard medication with bisoprolol